Trusted
Vtuls has six years of proof, has been deployed in seven countries and is approved by the FDA, CE and ISO.
Read about Vtuls on
Our market-leading AI and Machine Learning-driven technology is supporting clinicians and caregivers across the globe by enabling them to monitor vulnerable patients’ vital signs remotely and to respond rapidly to worsening conditions.
Vtuls has six years of proof, has been deployed in seven countries and is approved by the FDA, CE and ISO.
Data shows that Vtuls can reduce mortality rate, improve patient outcomes by 20% and reduce healthcare costs by 35%.
Vtuls’ flexible platform fully integrates into existing healthcare systems, can be deployed within 48 hours and is available to be branded as yours.
We are driven by using our expertise in healthcare, AI and enterprise software to create remote healthcare solutions that protect and improve the lives of vulnerable patients.
We make it easy for clinicians and caregivers to monitor the vital signs of their patients remotely through proven technology.
This benefits individuals by enabling a faster response to deterioration, greater independence, improved quality of life, less time spent in hospitals and a feeling of empowerment that comes with being engaged in your own healthcare.
For healthcare and residential organisations, the benefits – apart from better care – include huge cost savings and increased efficiency, thus enabling staff to engage better with the individual.
Vtuls enables clinicians and caregivers to monitor vital signs remotely to improve outcomes and quality of life for vulnerable patients and people with chronic conditions. Here’s how it works:
Starting with the patient, the leading edge Vtuls Biosensor device monitors five key vital signs – far more than any alternatives on the market – and is administered simply by the user holding the device in the palm of their hand for 20 seconds. The five vital signs are:
Blood pressure
Blood oxygen
Heart rate
ECG
Temperature
There is also a purpose-built Vtuls Mobile App – which can be white labelled – and which enables the flexible platform to integrate with other medical devices such as smartwatches and other wearables, as well as capture patient-reported vital signs such as pain and anxiety. In total, up to 40+ vital signs can be monitored.
Vtuls’ industry-leading AI and Machine Learning technology analyses the patients’ vital signs data on a daily basis through machine learning algorithms. This deep data analysis is coded and presented to the clinician or caregiver in an easy-to-use online portal, with red coding identifying deteriorating conditions. Clinicians can also enable patients to view the data for themselves and share it with their selected relatives and caregivers, increasing engagement in their health.
Patients who require intervention can be contacted by phone or video within the Vtuls mobile app. They can also be sent messages to remind them to take their vital signs in instances where this has been missed. This saves time and resource, enabling the patient to get access to the care they need without having to come to the hospital.
To see the Vtuls’ technology at work and learn more about its applications, schedule a demo with us here:
“Vtuls' technology has really helped us to improve the quality of our care. It's really easy-to-use for both patients and clinicians and it's meant that both parties are far more informed when it comes to the patient's health. From the clinicians point-of-view, being able to follow our patients' vital signs to monitor for deterioration and to be able to use the information to have an informed discussion during appointments has been a revelation and has helped us to further improve the quality of our care.„
“One of the major benefits of TeleCare North is that it allows us to perform healthcare tasks at the most efficient cost level. For instance, a GP or a municipal nurse now performs tasks that previously required an outpatient visit or hospitalisation.„
“Experiences from Aarhus show that telemedicine not only provides a more significant sense of security for the pregnant women and their relatives; it also allows for more Freedom.„
Find out the latest news on how Vtuls is working towards its mission of helping clinicians and caregivers to protect and improve the lives of vulnerable patients.
We are delighted to announce that Vtuls has been shortlisted in the ‘Best Use of AI’ category at The HTN Awards 2020. The Health Tech Newspaper (HTN) Awards 2020 celebrates great technology, partnerships and innovations that are really making a difference across the health and care sector. Vtuls was recognised by a panel of judges …
This week, The Times reported that there is to be a two month delay in the planned implementation of monthly testing for care home residents. The news follows a report by The Public Accounts committee that described the treatment of care homes during the Covid-19 pandemic as “reckless”. I have written before about how monthly …
